- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 11, 2024
Discovery & Translation
Science spotlight: An antidote to reverse anticoagulants, two ocular gene therapies, and more
BioCentury’s roundup of translational innovations
BioCentury | Apr 13, 2024
Discovery & Translation
Science spotlight: Tumors siphon taurine from T cells, and Revolution’s RAS (ON) inhibitors
BioCentury’s roundup of translational innovations
BioCentury | Apr 1, 2022
Distillery Therapeutics
Small molecule to control β cell ER stress in diabetes
BioCentury | Sep 10, 2021
Targets & Mechanisms
Integrated stress response key to seemingly disparate diseases?
A flurry of preclinical studies builds the case for the integrated stress response as a central driver of many diseases
BioCentury | Jun 22, 2017
Translation in Brief
TERS talk
Unfolding how cancer cells share ER stress-induced survival signals
BioCentury | Jul 21, 2016
Distillery Therapeutics
Therapeutics: Glutamic-pyruvic transaminase 2 (GPT2); activating transcription factor 4 (ATF4); phosphoinositide 3-kinase catalytic subunit α polypeptide (PI3KC
BioCentury | Jun 18, 2015
Distillery Therapeutics
Therapeutics: Activating transcription factor 4 (ATF4); heme oxygenase decycling 1 (HMOX1; HO-1; Hsp32)
Items per page:
1 - 10 of 10